Steve Conlan is Professor of Molecular and Cell Biology at Swansea University Medical School. He is head of the Reproductive Biology and Gynaecological Oncology research group, and Director of Strategic Partnerships for the Medical School.
Prof Conlan is a Fellow of the Royal Society of Biology (FRSB), and a Trustee of the British Society of Nanomedicine. He is a Senior Affiliate Member of The Methodist Hospital Research Institute, Houston Texas, and Distinguished Professor at Xi'an Jiaotong University, Suzhou Academy, China.
Steve has achieved success in developing infrastructure bids, strategic national and international collaborations, and industrial partnerships.
He was a founding Director of the £22 Million Centre for NanoHealth [CNH] at Swansea University, an interdisciplinary R&D facility bringing together clinicians, biologists, physicists, chemists, engineers and businesses together under one roof to deliver advances in nanomedicine.
Steve is now Strategic Director of the Celtic Advanced Life Science Innovation Network (CALIN), a €12Million Ireland-Wales INTERREG operation established to build a innovation bridge between Wales and Ireland in life sciences. CALIN partners include Swansea (lead), Bangor, Cardiff, University College Dublin, National University Galway, University College Cork.
He currently leads industry facing R&D projects with industrial partners including Axis Bioservices, Bruker nano, GSK, GE Healthcare, Ig Innovations (part of the Abbott group), Porvair, and ReNeuron.
Prof Conlan’s research focuses on the application of molecular, cellular and nano biology approaches to understanding gynaecological pathologies including cancer and infertility. He has a particular interest in the impact of aberrant transcription and epigenetic processes, and advanced therapeutics (Antibody Drug Conjugates, exosomes, and nanoparticle deliver systems). He is affiliated to the Wales Cancer Research Centre, a virtual network in Wales, where he coordinates activity in developing novel therapeutics for ovarian cancer with colleagues in Swansea and Cardiff.
As Director of Strategic Partnerships, and member of the University’s Internationalisation Strategy Group, he leads strategic collaborative initiatives with Grenoble - France, Houston - US and Suzhou and Wuhan – China.
Prof Conlan holds an honorary consultant position in the Abertawe Bro Morgannwg NHS Board, working with clinical colleagues in Singleton Hospital Swansea and The Princess of Wales Hospital Bridgend.